Transfusion Technologies

Transfusion Technologies Corporation was a specialized medical device company that developed innovative systems for autologous blood recovery and transfusion. The company's primary product, the OrthoPAT (Orthopedic Perioperative Autotransfusion) system, was designed to collect, wash, and reinfuse a patient's own red blood cells during and after orthopedic surgery. This technology provided a significant clinical advantage by reducing the risks associated with allogeneic blood transfusions, such as viral transmission and immunological reactions. Founded by Allen Latham Jr., a pioneer in blood processing technology, the company focused on improving surgical outcomes through automated blood management. In 2002, Transfusion Technologies was acquired by Haemonetics Corporation for approximately $60 million, integrating its autotransfusion technology into Haemonetics' broader surgical product suite.